William Summerskill, senior executive editor of The Lancet, addressed a special reportin our school

On the afternoon ofJune 9, William Summerskill, M.D., senior executive editor ofthe world authoritative medical journal The Lancet, together withPro. Jiang Lixin, the chief editor Chinese version of The Lancet and assistant director of the national center for cardiovascular disease anddeputy executive director of the national center for cardiovascular disease clinical research, were invited to give clinical research project reports for the “one hundred” and headmasters of multiple clinical centers. Chen Guoqiang, the president of our medical school, along with the relevant department and the head of the secondary schools, attended the meeting and communicated with the participating doctors and clinical researchers before the meeting. The report washost by Hu Yiqun, the deputy president of our medical school.

Giving a report of “14 avoidable pitfalls when publishing research”, Dr. Summerskill demonstratedrequired elements for the research results of world class standard journal. He pointed out that “there is great possibility for China to be leaders in the future in world science and technology not only in scientific research quantity, but also in cientific research quality”. In 2015, China ranked third in submission for The Lancet and eighth in volume, but there is still a lot of room for improvement in the quality of Chinese clinical research papers.He summarized 14common problems in papers from previous work and elaborated how to overcome and improve these problems to promote the competitiveness of research papers. He believed that it is the research which changes traditional thinking, research which arose widespread interest and researchwhichadopted scientific and rational methodology systems that were valuable research. He added,The Lancetwas keen to spread China‘s top research results to the world.

In the communication part, the clinicians and researchers asked questions actively, contributing to a heated talk,Dr. Summerskill responsed one by one and showed hisexpectation and confidencein Chinese high level scientific research. At the same time, he gave careful guidance to clinical researchers on how to further improve the research work and make the research results more international competitive.

In his summary, Hu Yiqunexpressed his sincere thanksfor the wonderful reportDr. Summerskill gave, and expect our clinical study to achieve the requirements of high starting point, high standardand high demand, to achieve good resultsafter a period of work, to gain global competencethroughplatforms ofinternational top journals like “The Lancet”, showing the strength of Chinese clinical medical research.

“The Lancet”,one ofthe most respectedmedical journalswith longest history and with highest peer reviews in the world, is currentlynot only one of the most authoritative academic journals in medicine in the world, but also one of the SCI journals withhighest impact factor. In addition to participate in all the matters from peer review to the editor’s commentary in The Lancet,especially responsible for the supervision of evaluating contents and schemes,Summerskill, Ph.D., also actively promoted clinical research in Asian countries, helped establishAsian editorial officeof “The Lancet” in 2010, whose office lacated in Beijing. He visited Asian countries to assist clinicians in conducting research and contributed to the publication of a Chinese special issue, a Japanese special issue and a southeast Asia ofThe Lancet. Dr. Summerskill is also a senior fellow at the evidence-based medicine center at Oxford University, who has accumulated rich clinical experience in basic health care during his tenure at the university of Bristol in England. Besides, he also has worked with several agenciesincluding the CONSORT, the Cochrane Collaboration, the United States Food and Drug Administration and the World Health Organization (WHO), always actively devoted to improving the design level and quality of study, promoting the development of the clinical research in developing countries, to put research results into clinical practice.